Home|Journals|Articles by Year|Audio Abstracts
 

Research Article

ECB. 2019; 8(3): 96-100


ANTIOXIDANT ACTIVITY OF COMPOUNDS ISOLATED FROM PYCNANTHUS ANGOLENSIS (WELW.) WARB AND BYROPHYLLUM PINNATUM (LAM.) OKEN

Olawale H. Oladimeji, Augustine A. Ahmadu.




Abstract

Pycnanthus angolensis (Welw.) Warb and Byrophyllum pinnatum (Lam.) Oken are two herbal recipes employed in native medicine for the treatment /management of gastrointestinal disorders, skin infections and more especially cancers, wounds and many other inflammatory conditions. Before now, seven compounds (NG-1b, NG-2, NG-3b, NG-4c, NG-5a, KF-1a and KF-2) have been obtained from the extracts of these plants by column and /or preparative thin-layer chromatographies. The search for new and more active antioxidant agents necessitated the screening of these compounds for potential activity. Generally the isolates gave (IC50) of between 0.50 and 0.60 μg mL-1. However, NG- 1b demonstrated a significant activity at 0.48 μg mL-1 which compare favourably with that shown by Vitamin A (a standard antioxidant drug) at 0.49 μg mL-1. These compounds, most especially NG-1b could be further worked on with the aim of improving on the observed antioxidant activity through in-vitro structural activity relationship studies (SARS) and probably in-vivo clinical trials

Key words: extracts; isolates; antioxidant; Pycnanthus angolensis; Byrophyllum pinnatum






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.